Valeria Rimoldi

Valeria Rimoldi

Auto-generated profile, based on publicly available information

Valeria Rimoldi

Department of Biomedical Sciences Humanitas University Milan Italy

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2003 in Oncogene
Verified
Journal Article
Closed access
PDF file
VRValeria Rimoldi
Valeria Rimoldi
ARAlessandra Reversi
Alessandra Reversi
ETElena Taverna
Elena Taverna
PRPatrizia Rosa
Patrizia Rosa
MFMaura Francolini
Maura Francolini
BCBice Chini
Bice Chini

1 April 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ARAlessandra Reversi
Alessandra Reversi
VRValeria Rimoldi
Valeria Rimoldi
TMTiziana Marrocco
Tiziana Marrocco
PCPaola Cassoni
Paola Cassoni
GBGiovanni Bussolati
Giovanni Bussolati
BCBice Chini
Bice Chini
In human myometrial cells, the promiscuous coupling of the oxytocin receptors (OTRs) to Gq and Gi leads to contraction. However, the activation of OTRs coupled to different G protein pathways can also trigger opposite cellular responses, e.g. OTR coupling to Gi inhibits, whereas its coupling to Gq stimulates, cell proliferation. Drug analogues capable of promoting a selective receptor-G protein coupling may be of great pharmacological and clinical importance because they may target only one specific signal transduction pathway. Here, we report that atosiban, an oxytocin derivative that acts as a competitive antagonist on OTR/Gq coupling, displays agonistic properties on OTR/Gi coupling, as shown by specific 35S-labeled guanosine 5′-3-O-(thio) trisphosphate ([35S]GTPγS) binding. Moreover, atosiban, by acting on a Gi-mediated pathway, inhibits cell growth of HEK293 and Madin-Darby canine kidney cells stably transfected with OTRs and of DU145 prostate cancer cells expressing endogenous OTRs. Notably, atosiban leads to persistent ERK1/2 activation and p21WAF1/CIP1 induction, the same signaling events leading to oxytocin-mediated cell growth inhibition via a Gi pathway. Finally, atosiban exposure did not cause OTR internalization and led to only a modest decrease (20%) in the number of high affinity cell membrane OTRs, two observations consistent with the finding that atosiban did not lead to any desensitization of the oxytocin-induced activation of the Gq-phospholipase C pathway. Taken together, these observations indicate that atosiban acts as a “biased agonist” of the human OTRs and thus belongs to the class of compounds capable of selectively discriminating only one among the multiple possible active conformations of a single G protein-coupled receptor, thereby leading to the selective activation of a unique intracellular signal cascade.

25 September 2018 in Gut Microbes
Verified
Journal Article
Closed access
FUFederica Ungaro
Federica Ungaro
LMLuca Massimino
Luca Massimino
FFFederica Furfaro
Federica Furfaro
VRValeria Rimoldi
Valeria Rimoldi
Laurent Peyrin-birouletLaurent Peyrin-biroulet
Laurent Peyrin-biroulet
SDSilvio Danese
Silvio Danese
Intestinal dysbiosis is one of the causes underlying the pathogenesis of inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD). Besides bacteria, microbiota comprises both prokaryotic and eukaryotic viruses, that together compose the gut virome. Few works have defined the viral composition of stools, while the virome populating intestinal mucosae from early-diagnosed IBD patients has never been studied. Here we show that, by in-depth metagenomic analysis of RNA-Seq data obtained from gut mucosae of young treatment-naïve patients, early-diagnosed for CD and UC, and from healthy subjects (Ctrl), UC patients display significantly higher levels of eukaryotic Hepadnaviridae transcripts by comparison with both Ctrl and CD patients, whereas CD patients show increased abundance of Hepeviridae versus Ctrl. Moreover, we found that UC gut mucosa is characterized by lower levels of Polydnaviridae and Tymoviridae, whereas the mucosa of patients with CD showed a reduced abundance of Virgaviridae. Our findings support the idea that certain eukaryotic viruses might trigger intestinal inflammation and contribute to IBD pathogenesis and pave the way not only for the discovery of novel diagnostic biomarkers but also for the development of anti-viral drugs for the treatment of IBD.

Verified
Journal Article
Open access
PDF file
GCGiulia Cardamone
Giulia Cardamone
EPElvezia Maria Paraboschi
Elvezia Maria Paraboschi
VRValeria Rimoldi
Valeria Rimoldi
SDStefano Duga
Stefano Duga
GSGiulia Soldà
Giulia Soldà
Rosanna AsseltaRosanna Asselta
Rosanna Asselta
Abnormalities in alternative splicing (AS) are emerging as recurrent features in autoimmune diseases (AIDs). In particular, a growing body of evidence suggests the existence of a pathogenic association between a generalized defect in splicing regulatory genes and multiple sclerosis (MS). Moreover, several studies have documented an unbalance in alternatively-spliced isoforms in MS patients possibly contributing to the disease etiology. In this work, using a combination of PCR-based techniques (reverse-transcription (RT)-PCR, fluorescent-competitive, real-time, and digital RT-PCR assays), we investigated the alternatively-spliced gene encoding Gasdermin B, GSDMB, which was repeatedly associated with susceptibility to asthma and AIDs. The in-depth characterization of GSDMB AS and backsplicing profiles led us to the identification of an exonic circular RNA (ecircRNA) as well as of novel GSDMB in-frame and out-of-frame isoforms. The non-productive splicing variants were shown to be downregulated by the nonsense-mediated mRNA decay (NMD) in human cell lines, suggesting that GSDMB levels are significantly modulated by NMD. Importantly, both AS isoforms and the identified ecircRNA were significantly dysregulated in peripheral blood mononuclear cells of relapsing-remitting MS patients compared to controls, further supporting the notion that aberrant RNA metabolism is a characteristic feature of the disease.

5 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LSLetizia Straniero
Letizia Straniero
VRValeria Rimoldi
Valeria Rimoldi
MSMaura Samarani
Maura Samarani
SGStefano Goldwurm
Stefano Goldwurm
Alessio Di FonzoAlessio Di Fonzo
Alessio Di Fonzo
Rosanna AsseltaRosanna Asselta
Rosanna Asselta
Mutations in the GBA gene, encoding lysosomal glucocerebrosidase, represent the major predisposing factor for Parkinson’s disease (PD), and modulation of the glucocerebrosidase activity is an emerging PD therapy. However, little is known about mechanisms regulating GBA expression. We explored the existence of a regulatory network involving GBA, its expressed pseudogene GBAP1, and microRNAs. The high level of sequence identity between GBA and GBAP1 makes the pseudogene a promising competing-endogenous RNA (ceRNA), functioning as a microRNA sponge. After selecting microRNAs potentially targeting both transcripts, we demonstrated that miR-22-3p binds to and down-regulates GBA and GBAP1, and decreases their endogenous mRNA levels up to 70%. Moreover, over-expression of GBAP1 3′-untranslated region was able to sequester miR-22-3p, thus increasing GBA mRNA and glucocerebrosidase levels. The characterization of GBAP1 splicing identified multiple out-of-frame isoforms down-regulated by the nonsense-mediated mRNA decay, suggesting that GBAP1 levels and, accordingly, its ceRNA effect, are significantly modulated by this degradation process. Using skin-derived induced pluripotent stem cells of PD patients with GBA mutations and controls, we observed a significant GBA up-regulation during dopaminergic differentiation, paralleled by down-regulation of miR-22-3p. Our results describe the first microRNA controlling GBA and suggest that the GBAP1 non-coding RNA functions as a GBA ceRNA.

11 September 2017 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
LSLetizia Straniero
Letizia Straniero
IGIlaria Guella
Ilaria Guella
RCRoberto Cilia
Roberto Cilia
LPLaura Parkkinen
Laura Parkkinen
VRValeria Rimoldi
Valeria Rimoldi
SDStefano Duga
Stefano Duga